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Objective: To analyze the clinical and epidemiologic characteristics of juvenile-onset spondy-
loarthritis (SpA) (< 16 years) and compare them with a group of adult-onset (≥ 16 years) SpA
patients.
Patients and methods: Prospective, observational and multicentric cohort with 1,424 patients
with the diagnosis of SpA according to the European Spondyloarthropathy Study Group
(ESSG) submitted to a common protocol of investigation and recruited in 29 reference cen-
ters  participants of the Brazilian Registry of Spondyloarthritis (RBE – Registro Brasileiro de
Espondiloartrites).  Patients were divided in two groups: age at onset < 16 years (JOSpA group)
and  age at onset ≥ 16 years (AOSpA group).
Results: Among the 1,424 patients, 235 presented disease onset before 16 years (16.5%). The
clinical and epidemiologic variables associated with JOSpA were male gender (p < 0.001),
lower limb arthritis (p = 0.001), enthesitis (p = 0.008), anterior uveitis (p = 0.041) and posi-
tive  HLA-B27 (p = 0.017), associated with lower scores of disease activity (Bath Ankylosing
Spondylitis Disease Activity Index – BASDAI; p = 0.007) and functionality (Bath Ankylosing
Spondylitis Functional Index – BASFI; p = 0.036). Cutaneous psoriasis (p < 0.001), inﬂamma-
tory bowel disease (p = 0.023), dactylitis (p = 0.024) and nail involvement (p = 0.004) were more
frequent in patients with adult-onset SpA.
Conclusions: Patients with JOSpA in this large Brazilian cohort were characterized predomi-
nantly by male gender, peripheral involvement (arthritis and enthesitis), positive HLA-B27
and  lower disease scores.
© 2014 Elsevier Editora Ltda. All rights reserved.
Perﬁl  epidemiológico  da  espondiloartrite  de  início  juvenil  comparada  com
a  espondiloartrite  de  início  na  vida  adulta  em  uma  grande  coorte
brasileira
alavras-chave:
spondiloartrite de início juvenil
opulac¸ão brasileira
pidemiologia
rtrite crônica na infância
rtrite relacionada à entesite
r  e  s  u  m  o
Objetivo: Analisar as características clínicas e epidemiológicas da espondiloartrite (EspA) de
início juvenil (< 16 anos) e compará-las com um grupo de pacientes com EspA de início na
vida adulta (≥ 16 anos).
Pacientes e métodos: Coorte prospectiva, observacional e multicêntrica com 1.424 pacientes
com  diagnóstico de EspA de acordo com o European Spondyloarthropathy Study Group (ESSG)
submetidos a um protocolo comum de investigac¸ão e recrutados em 29 centros de referência
participantes do Registro Brasileiro de Espondiloartrites (RBE). Os pacientes foram divididos
em  dois grupos: idade no início < 16 anos (grupo EspAiJ) e idade no início ≥ 16 anos.
Resultados: Entre os 1.424 pacientes, 235 manifestaram o início da doenc¸a antes dos 16
anos  (16,5%). As variáveis clínicas e epidemiológicas associadas com a EspAiJ foram: gênero
masculino (p < 0,001), artrite em membro inferior (p = 0,001), entesite (p = 0,008), uveíte ante-
rior  (p = 0,041) e HLA-B27 positivo (p = 0,017), em associac¸ão com escores mais baixos de
atividade da doenc¸a (Bath Ankylosing Spondylitis Disease Activity Index – BASDAI; p = 0,007)
e  de capacidade funcional (Bath Ankylosing Spondylitis Functional Index – BASFI; p = 0,036). Apsoríase cutânea (p < 0,001), a doenc¸a intestinal inﬂamatória (p = 0,023), a dactilite (p = 0,024)
e  o envolvimento ungueal (p = 0,004) foram mais frequentes em pacientes com EspA de início
na  vida adulta.
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Conclusões: Nessa grande coorte brasileira, os pacientes com EspAiJ se caracterizavam
predominantemente pelo gênero masculino, envolvimento periférico (artrite e entesite),
HLA-B27 positivo e escores de doenc¸a mais baixos.
© 2014 Elsevier Editora Ltda. Todos os direitos reservados.Introduction
Most patients with SpA start disease in the adult age. Recog-
nizing juvenile-onset SpA (JOSpA) can be a challenge, as many
patients present the classic manifestations of the disease in
the 3rd to 4th decades of life. Nevertheless, as SpA can start at a
pediatric age, it is important the early diagnosis of the disease,
contributing to avoid structural damage and the consequent
functional incapacity in adult age.1
Most patients with JOSpA can present an undifferentiated
form of disease, characterized by the presence of peripheral
arthritis, enthesitis and hip involvement, on the contrast of
adult-onset patients, who  present more  frequently the axial
complaints characteristic of SpA. As a consequence of this
presentation, JOSpA can be confounded with other forms of
juvenile arthritis.2
Nowadays, classiﬁcation criteria for JOSpA are included in
the International League Against Rheumatism (ILAR) criteria
for juvenile idiopathic arthritis. Many  cases of JOSpA can be
considered as enthesitis-related arthritis (ERA) if they present
arthritis and/or enthesitis associated with at least two of these
variables: (1) presence or a history of sacroiliac joint tender-
ness and/or inﬂammatory lumbosacral pain; (2) presence of
HLA-B27 antigen; (3) onset of arthritis in a male over 6 years
of age; (4) acute symptomatic anterior uveitis; (5) history of
ankylosing spondylitis, enthesitis related arthritis, sacroilitis
with inﬂammatory bowel disease, reactive arthritis or acute
anterior uveitis in a ﬁrst-degree relative. Exclusion criteria
include psoriasis or history of psoriasis in the patient or in
a ﬁrst-degree relative; presence of positive rheumatoid factor
in at least two occasions in a three month interval; or systemic
juvenile idiopathic arthritis.3 Patients classiﬁed as enthesitis-
related arthritis under the current ILAR classiﬁcation criteria
for juvenile idiopathic arthritis can in fact represent early
cases of JOSpA.
Recently, the proposition of the classiﬁcation criteria for the
peripheral SpA can include many  juvenile patients with undif-
ferentiated arthritis or ERA in the group of SpA.4 The modern
concept of peripheral SpA consider that patients with arthri-
tis or enthesitis or dactylitis with at least one (anterior uveitis;
psoriasis; Crohn’s disease or ulcerative colitis; preceding infec-
tion; positive HLA-B27; sacroilitis by imaging) or two (arthritis;
enthesitis; dactilitis; inﬂammatory low back pain somehow;
family history of SpA) characteristics should be considered as
a SpA.The main objectives of this article are to analyze the clinic
and epidemiologic characteristics of patients with JOSpA in
a large cohort of patients with SpA, and compare them withthose presented by patients with adult-onset SpA in the same
cohort.
Methods
This is a prospective, observational and multicentric cohort
of consecutive SpA patients recruited from 29 referral cen-
ters participants in the RBE (RBE –). All these SpA patients,
from all the ﬁve major geographic areas in Brazil, were
classiﬁed according to the ESSG,5 with the data collected
from June 2006 to December 2009. The Brazilian Reg-
istry of Spondyloartrhritis is part of the RESPONDIA group,
constituted by nine Latin-American countries (Argentina,
Brazil, Costa Rica, Chile, Ecuador, Mexico, Peru, Uruguay and
Venezuela) and the two Iberian Peninsula countries (Spain and
Portugal).
In this study, a common protocol of investigation was
applied to 1,424 SpA patients. The diagnosis of ankylos-
ing spondylitis was considered if the patients fulﬁlled the
New York modiﬁed criteria,6 and as psoriatic arthritis in
case they fulﬁlled Moll and Wright criteria;7 reactive arthritis
was considered when asymmetric inﬂammatory oligoarthritis
of lower limbs was present associated with enthesopa-
thy and/or inﬂammatory low back pain following enteric
or urogenital infections,8 and enteropathic arthritis when
the patient presented inﬂammatory axial and/or peripheral
joint involvement associated with conﬁrmed inﬂamma-
tory bowel disease (IBD) (Crohn’s disease or ulcerative
colitis).
Patients were divided in two groups: JOSpA was considered
when the patient started SpA symptoms < 16 years of age, and
adult-onset SpA was considered when disease onset was ≥ 16
years.
Demographic and clinical data were collected includ-
ing time of disease duration, extra-articular manifestations,
and treatment. Erythrocyte sedimentation rate (ESR) and C-
reactive protein (CRP) values were also registered.
Disease activity and functional status were evaluated
according to the BASDAI and the Bath Ankylosing Spondyli-
tis Functional Index (BASFI),9,10 respectively. The presence
of pain at entheses sites was evaluated by the Maastricht
Ankylosing Spondylitis Enthesitis Score (MASES);11 the MASES
scores varied from 0 to 13. Quality of life data has been
recorded through Ankylosing Spondylitis Quality of Life
12(ASQoL) questionnaires. All questionnaires used were pre-
viously translated, cross-translated, validated and culturally
adapted to the Portuguese language.13
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Figure 1 – Mean scores of the disease activity (BASDAI), functional (BASFI), and quality of life (ASQoL) indexes in the
juvenile-onset SpA group (JOSpA) compared with the adult-onset SpA group (AOSpA).
ASQoL, Ankylosing Spondylitis Quality of Life; BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath
Ankylosing Spondylitis Functional Index.
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esults
mong the 1,424 SpA patients, 235 referred disease onset
efore 16 years (16.5%). At the moment, they were evaluated
or the SpA protocol, just 3.0% of the patients were below
6 years. Patients considered as JOSpA presented signiﬁcant
elay in the diagnosis (10.02 ± 9.28 years vs. 5.84 ± 7.27 years; P
 0.001) compared to the adult-onset patients. At the moment
f the clinical investigation, JOSpA patients were signiﬁcantly
ounger (32.53 ± 11.78 years) than the adult-onset patients
44.51 ± 11.94 years) (P < 0.001).
The clinical and epidemiologic variables associated with
OSpA were male gender (P < 0.001), lower limb arthri-
is (P = 0.001), enthesitis (P = 0.008), and positive HLA-B27
P = 0.017). Inﬂammatory back pain (P = 0.006), cervical pain (P =
.034) and dactylitis (P = 0.024) were more  frequent in patients
ith adult-onset SpA (Table 1). Ethnicity was similar in both
ge-onset groups.
When we studied the extra-articular manifestations, ante-
ior uveitis (P = 0.041) was associated with JOSpA, while
utaneous psoriasis (P < 0.001), inﬂammatory bowel disease(P = 0.023), and nail involvement (P = 0.004) were associated to
adult-onset SpA (Table 1).
The analysis of the physical examination showed that the
mean number of painful joints (3.40 ± 6.99 vs. 3.83 ± 7.52;
P = 0.423), mean number of swollen joints (1.19 ± 3.73 vs.
1.58 ± 4.62; P = 0.183), as well as the mean MASES scores
(2.04 ± 2.89 vs. 2.17 ± 3.02; P = 0.548) were similar in the two
groups.
Disease indices indicated that disease activity (BASDAI; P
= 0.007) and functionality (BASFI; P = 0.036) were better in the
JOSpA group, while ASQoL (P = 0.088) did not reach statistical
signiﬁcance (Fig. 1).
Discussion
The clinical characteristics of this cohort have shown concor-
dance with the classic description of JOSpA:3 predominance
of male gender, positive HLA-B27, and peripheral involvement
characterized by lower limb arthritis and enthesitis. These
characteristics also agree with the concept of the peripheral
SpA.4
Most studies about JOSpA in fact analyze ankylosing
spondylitis juvenile.14–19 In this study, we  found a statistical
predominance of the male gender in JOSpA. Other recent
studies have found similar gender prevalence in their cohorts
in Canada and China,14,15 while Gensler et al. in USA showed
a trend to present more  women in juvenile ankylosing
spondylitis.16
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Table 1 – Associations between clinic-epidemiologic variables and age at onset (before and after 16 years-old) in 1,424
patients.
Variables Age at onset of symptoms pa
< 16 years ≥ 16 years
n = 235 % n = 1189 %
Gender < 0.001
Male 202 86.0 839 70.6
Female 33 14.0 350 29.4
Ethnicity 0.621
White 121 51.5 686 57.7
Non-white 114 48.5 503 42.3
Inﬂammatory low back pain 142 60.4 827 69.6 0.006
Buttock pain 81 34.5 396 33.3 0.730
Cervical pain 60 25.5 387 32.5 0.034
Hip pain 71 30.2 294 24.7 0.078
Lower limb arthritis 140 59.6 563 47.4 0.001
Upper limb arthritis 47 20.0 274 23.0 0.307
Enthesitis 137 58.3 581 48.9 0.008
Dactilitis 17 7.2 147 12.4 0.024
HLA-B27b 82 79.6 396 67.9 0.024
Anterior uveitis 59 25.1 229 19.3 0.041
Inﬂammatory bowel disease 4 1.7 61 5.1 0.021
Psoriasis 9 3.8 245 20.6 < 0.001
Nail involvement 11 4.7 129 10.8 0.004
Balanitis 11 4.7 37 3.1 0.223
a Qui-square.
b Calculated for 103 (< 16 years) and 583 patients (≥ 16 years).JOSpA and adult-onset SpA, particularly ankylosing
spondylitis, can differ in some clinical aspects, but there is no
evidence that they could be considered as different diseases.
The main differences are in the disease presentation. Different
from what happens in the adult-onset patients, children and
adolescents with JOSpA frequently start disease symptoms
with peripheral complaints (lower limb arthritis and enthe-
sitis), and will develop axial symptoms after ﬁve to 10 years of
follow-up.14–20 In the present study, the authors found a signif-
icant frequency of lower limb arthritis and enthesitis in JOSpA.
This study also showed that there was a signiﬁcant delay in
the diagnosis of JOSpA compared to adult-onset SpA patients;
we  suppose that this delay is associated with the many  times
undifferentiated clinical presentation of SpA in children and
teenagers.
Regarding extra-articular manifestations, the present
study found that anterior uveitis was more  frequent in the
JOSpA group, while psoriasis, nail involvement and inﬂam-
matory bowel disease were more  frequent in the adult-onset
group. These ﬁndings are similar to the results observed in
other cohorts.14,19,21 In a Turkish study, uveitis was observed in
11.6% of the patients with juvenile idiopathic arthritis and was
related to the clinical form, associated with the oligoarticular
(extended and persistent) and psoriatic forms.21
The frequency of positive HLA-B27 in the JOSpA group was
signiﬁcantly higher than that observed in the adult-onset SpA
group. These results were similar to other studies including
European and Asiatic populations,21–23 and conﬁrm that HLA-
B27 should be done in all the patients suspected to have SpA,according to its elevated positivity and association with more
severe disease.23
The severity of ankylosing spondylitis is frequently high
in juvenile cases as there are many  patients with juve-
nile ankylosing spondylitis who require hip arthroplasty.
The results of functional incapacity in patients with JOSpA
can be discordant. While Stone et al.24 have found a
worse functional capacity in juvenile ankylosing spondylitis
patients, Gensler et al.16 showed similar results compared to
adult-onset patients. In the present study, BASDAI and BASFI
mean scores were signiﬁcantly lower in the JOSpA patients,
while ASQoL scores were similar in the two groups. These ﬁnd-
ings can suggest that the impact of SpA in the quality of life in
the juvenile group is high, despite better disease activity and
functional indices.
Despite the lower frequency of axial involvement in the
JOSpA, studies have demonstrated 40% of functional incapac-
ity after 10 to 15 years of disease duration is signiﬁcantly
associated with hip involvement.16,25 In another study with
326 JOSpA patients, mean BASFI was 5.1 ± 1.5, signiﬁcantly
higher than the BASFI of the adult-onset SpA group (4.6 ±
0.4).24 In a 3-year Norwegian prospective study analyzing the
predictors of disability in JOSpA by the Children Health Assess-
ment Questionnaire (CHAQ), the authors found that a high
disability index and a poor well-being at baseline predicted
reduced physical function after 3 years.26 Compared to other
subgroups of juvenile idiopathic arthritis, patients with juve-
nile ankylosing spondylitis referred more  chronic pain and
higher scores of CHAQ, associated to poorer quality of life.27
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Concluding, the present study, analyzing a large Brazilian
ohort of patients with SpA, attended in university centers in
ll the main geographic regions in the country, showed that
OSpA was associated with male gender, HLA-B27 positivity,
nterior uveitis and peripheral involvement. This character-
zation will help to understand the characteristics of the
OSpA patients and their needs in the long-term follow
p.
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